BioCorRx Inc.
BICX
$0.35
$0.025.30%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -55.50% | -46.59% | 27.75% | 21.70% | -22.19% |
| Total Depreciation and Amortization | 0.24% | 136.71% | 53.78% | 39.75% | -30.90% |
| Total Amortization of Deferred Charges | 2.67% | -27.99% | -25.50% | 1.78% | -39.77% |
| Total Other Non-Cash Items | 2,530.79% | -85.08% | -5.79% | -55.34% | 615.49% |
| Change in Net Operating Assets | -106.76% | 354.32% | -193.10% | 76.87% | -64.60% |
| Cash from Operations | -401.50% | 81.66% | -178.96% | 30.85% | -135.35% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -55.73% | -66.10% | 87.59% | -5.88% | 502.69% |
| Total Debt Repaid | -25.00% | 94.59% | -208.33% | 74.47% | -2,250.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 278.29% | -65.77% | 86.72% | -4.07% | 490.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.46% | 237.25% | -172.70% | 1,159.04% | 91.05% |